Anterogen.Co.,Ltd. (065660.KQ)
KRW 22550.0
(-0.44%)
KRW 22550.0
(-0.44%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 9.74 Billion KRW | -23.37% |
| 2022 | 12.71 Billion KRW | 7.99% |
| 2021 | 11.77 Billion KRW | 27.21% |
| 2020 | 9.25 Billion KRW | -30.28% |
| 2019 | 13.27 Billion KRW | -66.67% |
| 2018 | 39.82 Billion KRW | 327.2% |
| 2017 | 9.32 Billion KRW | 0.0% |
| 2016 | - KRW | 0.0% |
| 2015 | - KRW | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - KRW | -100.0% |
| 2024 Q2 | - KRW | 0.0% |
| 2023 Q2 | 9.07 Billion KRW | -31.03% |
| 2023 Q4 | 9.74 Billion KRW | 3.64% |
| 2023 FY | 9.74 Billion KRW | -23.37% |
| 2023 Q1 | 13.15 Billion KRW | 3.47% |
| 2023 Q3 | 9.39 Billion KRW | 3.61% |
| 2022 FY | 12.71 Billion KRW | 7.99% |
| 2022 Q4 | 12.71 Billion KRW | 3.53% |
| 2022 Q3 | 12.27 Billion KRW | 3.61% |
| 2022 Q1 | 11.42 Billion KRW | -2.92% |
| 2022 Q2 | 11.85 Billion KRW | 3.71% |
| 2021 Q4 | 11.77 Billion KRW | 3.53% |
| 2021 FY | 11.77 Billion KRW | 27.21% |
| 2021 Q3 | 11.36 Billion KRW | 2.72% |
| 2021 Q1 | 20.08 Billion KRW | 117.07% |
| 2021 Q2 | 11.06 Billion KRW | -44.89% |
| 2020 Q2 | 8.62 Billion KRW | 17.34% |
| 2020 Q3 | 8.88 Billion KRW | 3.08% |
| 2020 Q4 | 9.25 Billion KRW | 4.12% |
| 2020 FY | 9.25 Billion KRW | -30.28% |
| 2020 Q1 | 7.34 Billion KRW | -11.98% |
| 2019 Q3 | 9.03 Billion KRW | -33.9% |
| 2019 Q2 | 13.67 Billion KRW | -54.46% |
| 2019 Q1 | 30.02 Billion KRW | 1.82% |
| 2019 FY | 13.27 Billion KRW | -66.67% |
| 2019 Q4 | 8.34 Billion KRW | -7.66% |
| 2018 Q3 | 38.51 Billion KRW | 1.81% |
| 2018 Q4 | 29.49 Billion KRW | -23.43% |
| 2018 FY | 39.82 Billion KRW | 327.2% |
| 2018 Q1 | 9.38 Billion KRW | 0.64% |
| 2018 Q2 | 37.83 Billion KRW | 303.29% |
| 2017 Q3 | 10 Billion KRW | 0.0% |
| 2017 Q1 | - KRW | 0.0% |
| 2017 Q2 | - KRW | 0.0% |
| 2017 Q4 | 9.32 Billion KRW | -6.79% |
| 2017 FY | 9.32 Billion KRW | 0.0% |
| 2016 FY | - KRW | 0.0% |
| 2016 Q1 | - KRW | 0.0% |
| 2016 Q2 | - KRW | 0.0% |
| 2016 Q4 | - KRW | 0.0% |
| 2016 Q3 | - KRW | 0.0% |
| 2015 Q4 | - KRW | 0.0% |
| 2015 FY | - KRW | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| HLB Co., Ltd. | 62.7 Billion KRW | 84.466% |
| iNtRON Biotechnology, Inc. | 402.9 Million KRW | -2317.515% |
| BINEX Co., Ltd. | 53.5 Billion KRW | 81.796% |
| Bioneer Corporation | 44.63 Billion KRW | 78.18% |
| MEDIPOST Co., Ltd. | 52.33 Billion KRW | 81.389% |
| CrystalGenomics, Inc. | 32 Billion USD | 69.564% |
| Helixmith Co., Ltd | 20.22 Billion KRW | 51.846% |
| Chabiotech Co.,Ltd. | 449.63 Billion KRW | 97.834% |
| Medy-Tox Inc. | 82.83 Billion KRW | 88.241% |
| Peptron, Inc. | 9.13 Billion KRW | -6.651% |
| Amicogen, Inc. | 149.59 Billion KRW | 93.489% |
| Genexine, Inc. | 67.42 Billion KRW | 85.554% |
| HLB Therapeutics Co.,Ltd. | 10.02 Billion KRW | 2.813% |
| LegoChem Biosciences, Inc. | 12.64 Billion KRW | 22.964% |
| ALTEOGEN Inc. | 83.76 Billion KRW | 88.372% |
| PharmaResearch Co., Ltd. | 34.3 Billion KRW | 71.608% |
| SillaJen, Inc. | 9.69 Billion KRW | -0.452% |
| JETEMA, Co., Ltd. | 130.49 Billion KRW | 92.536% |
| OliX Pharmaceuticals,Inc | 39.35 Billion KRW | 75.251% |
| Genomictree Inc. | 1.83 Billion KRW | -430.911% |
| MedPacto, Inc. | 8.6 Billion KRW | -13.206% |
| D&D Pharmatech | 8.13 Billion KRW | -19.745% |
| EASY BIO,Inc. | 82.27 Billion KRW | 88.162% |
| GI Innovation, Inc. | 3.72 Billion KRW | -161.78% |